سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Mesenchymal stem cells engineered through nanoparticles containing cancer diagnostic and therapeutic agents

Publish Year: 1401
Type: Conference paper
Language: English
View: 313

This Paper With 13 Page And PDF Format Ready To Download

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

Export:

Link to this Paper:

Document National Code:

SDNCONF07_019

Index date: 28 June 2022

Mesenchymal stem cells engineered through nanoparticles containing cancer diagnostic and therapeutic agents abstract

Numerous studies have shown that nanoparticles containing diagnostic and therapeutic agents as well as mesenchymal stem cells (MSCs) are useful in the treatment of various cancers. Nanoparticles are actually used to improve the accuracy of diagnosis and treatment. In addition to their unique therapeutic properties, MSCs can target treatment due to their tumor tropism capability. It has been shown that diagnostic and therapeutic agents reach the tumor site through these cells. It has also been shown that, in addition to creating a great synergy in cancer diagnosis and treatment, nanoparticle-based cell engineering can help overcome the limitations of these two approaches. As a result, some valuable studies on these two approaches will be discussed

Mesenchymal stem cells engineered through nanoparticles containing cancer diagnostic and therapeutic agents Keywords:

Mesenchymal stem cells engineered through nanoparticles containing cancer diagnostic and therapeutic agents authors

Reza Naeimi

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Razieh Amini

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Maryam Hoseinpour

Department of Medical Genetics, Mashhad University of Medical Sciences, Mashhad, Iran